Vote Scores

Home / Companies / Ocular Therapeutix, Inc.

Company · votes reported on Form N-PXOCUL · SEC company no. 1393434

Ocular Therapeutix, Inc.

How funds and institutional managers reported voting their shares, year to 30 June 2026

Filers reporting
326year to 30 June 2026
Against management on pay
63.0%187 of 297 reporting filers
Same, by reported shares
21.6%shares reported on Form N-PX
Meetings on file
3across 3 seasons
32.4% for59.2% against8.4% other63.0% against management321 filers on say-on-pay

foragainstabstain, withhold or otheramber tick: the portion cast against management

326 Form N-PX filers reported votes at Ocular Therapeutix, Inc. for the year to 30 June 2026, across one meeting.

On the advisory vote on executive pay, 187 of the 297 filers that reported a position voted against management (63.0%), 56.4 percentage points above the median company on this site (6.6%). By reported shares the figure is 21.6% (median 2.9%). These are shares of the filers reporting on Form N-PX, not of all votes cast at the meeting.

Among the largest fund families, 12 voted with management on pay and 25 voted against: PGIM and Prudential, Northern Trust and FlexShares, DWS, BNY Mellon, Dimensional, Victory Capital, Allspring and ProShares and ProFunds and others.

Meetings

Meeting dateSeasonFilers reportingItemsAgainst management on pay
10 Jun 2026year to 30 June 2026324563.0%
11 Jun 2025year to 30 June 2025251664.4%
12 Jun 2024year to 30 June 2024189521.3%

Meetings with 20 or more reporting filers have their own page with every item. Dates are as filers typed them; dates up to three days apart are treated as one meeting.

Say-on-pay: this company and the median

year to 30 June 2026Ocular Therapeutix, Inc.Median company
Reporting filers voting against management63.0%6.6%
Reported shares voted against management21.6%2.9%

Among filers reporting on Form N-PX. The median is over 3,799 companies with a say-on-pay item reported by 20 or more filers.

How the largest families voted

Meeting of 10 Jun 2026: say-on-pay and each shareholder proposal that could be told apart.

FamilySay-on-pay
VanguardFor
BlackRock and iSharesAgainst *
FidelityFor
DimensionalAgainst *
State Street and SPDRAgainst *
InvescoAgainst *
EquitableFor
Charles SchwabAgainst *
Nuveen and TIAAFor
ProShares and ProFundsAgainst *
John Hancock and ManulifeAgainst *
Morgan Stanley, Eaton Vance and CalvertAgainst *
J.P. MorganFor
Goldman SachsFor
PGIM and PrudentialAgainst *
Jackson National fundsAgainst *
Northern Trust and FlexSharesAgainst *
SEIAgainst *
T. Rowe PriceFor
Lincoln FinancialAgainst *
VoyaAgainst *
Russell InvestmentsAgainst *
NationwideAgainst *
Victory CapitalAgainst *
Brighthouse FundsFor
Guggenheim and RydexAgainst *
Columbia ThreadneedleAgainst *
BNY MellonAgainst *
PrincipalFor
Pacific Life fundsAgainst *
Global XAgainst *
TransamericaFor
AllianceBernsteinFor
DWSAgainst *
AllspringAgainst *
MassMutualFor
Neuberger BermanAgainst *

* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.

By season

SeasonFilers reportingAgainst management on pay, filersBy reported sharesSay-on-pay split
year to 30 June 202419021.3%withheld
year to 30 June 202525264.4%27.8%
year to 30 June 202632663.0%21.6%

Category mix

Share of the vote records reported for this company, by the category filers chose.

CategoryVote recordsShare
SECTION 14A SAY-ON-PAY VOTES1,54541.5%
DIRECTOR ELECTIONS98026.3%
COMPENSATION54914.8%
AUDIT-RELATED42111.3%
CAPITAL STRUCTURE1173.1%
CORPORATE GOVERNANCE1092.9%

Questions

How did large funds vote at Ocular Therapeutix, Inc.?

For the year to 30 June 2026, 297 Form N-PX filers reported a say-on-pay vote at Ocular Therapeutix, Inc.; 187 voted against management (63.0%). The table on this page lists the position of each of the largest fund families on say-on-pay and on each shareholder proposal that could be told apart in the filings.

Were there shareholder proposals at Ocular Therapeutix, Inc.?

No proposal from security holders was reported by enough filers to be shown for the year to 30 June 2026.

Is this the meeting result?

No. The figures are shares of the funds and managers that file Form N-PX, and of the shares they reported. Holders that do not file the form (individuals, most foreign investors, insiders) are not included, so the split here can differ widely from the certified result, which Ocular Therapeutix, Inc. reports on Form 8-K.

Where does the data come from?

From Form N-PX filings on the SEC's EDGAR system, grouped by company. Filers type company names and meeting dates themselves; this site groups spellings of the same company and folds meeting dates up to three days apart. Data runs through 23 Sep 2026; the median compares 3,799 companies.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list Ocular Therapeutix, Inc., grouped by company. The name is the most common spelling among filers; the ticker and SEC company number come from the SEC company tickers file, matched on the exact name. Not verified by the SEC. Filings read through 23 Sep 2026; page built 26 Sep 2026.